+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Prostate Cancer Drugs Market Research Reports

From
Metastatic Castration-Resistant Prostate Cancer- Pipeline Insight, 2025 - Product Thumbnail Image

Metastatic Castration-Resistant Prostate Cancer- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 240 Pages
  • Global
From
Metastatic Prostate Cancer- Pipeline Insight, 2025 - Product Thumbnail Image

Metastatic Prostate Cancer- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 180 Pages
  • Global
From
From
Prostate Cancer Devices - Global Strategic Business Report - Product Thumbnail Image

Prostate Cancer Devices - Global Strategic Business Report

  • Report
  • August 2025
  • 276 Pages
  • Global
From
From
Metastatic Hormone Refractory Prostate Cancer - Pipeline Insight, 2025 - Product Thumbnail Image

Metastatic Hormone Refractory Prostate Cancer - Pipeline Insight, 2025

  • Clinical Trials
  • July 2025
  • 450 Pages
  • Global
From
Metastatic Castration-Sensitive Prostate Cancer - Pipeline Insight, 2025 - Product Thumbnail Image

Metastatic Castration-Sensitive Prostate Cancer - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Benign Prostatic Hyperplasia - Pipeline Insight, 2025 - Product Thumbnail Image

Benign Prostatic Hyperplasia - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Prostate Cancer- Pipeline Insight, 2025 - Product Thumbnail Image

Prostate Cancer- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 180 Pages
  • Global
From
Leuprolide Acetate Market 2025-2029 - Product Thumbnail Image

Leuprolide Acetate Market 2025-2029

  • Report
  • June 2025
  • 198 Pages
  • Global
From
From
From
Metastatic Castration Resistant Prostate Cancer Market - Product Thumbnail Image

Metastatic Castration Resistant Prostate Cancer Market

  • Report
  • January 2025
  • 250 Pages
  • Global
From
Prostate Cancer: Epidemiology Forecast to 2033 - Product Thumbnail Image

Prostate Cancer: Epidemiology Forecast to 2033

  • Report
  • February 2025
  • 51 Pages
  • Global
From
Metastatic Prostate Cancer Drug Pipeline Analysis Report 2025 - Product Thumbnail Image

Metastatic Prostate Cancer Drug Pipeline Analysis Report 2025

  • Drug Pipelines
  • June 2025
  • 200 Pages
  • Global
From
Loading Indicator

The Prostate Cancer Drugs market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs used to treat prostate cancer. Prostate cancer is the most common cancer in men, and the drugs used to treat it can vary depending on the stage and severity of the disease. Common treatments include hormone therapy, chemotherapy, and radiation therapy. The Prostate Cancer Drugs market is highly competitive, with many companies vying for market share. Major players in the market include Astellas Pharma, Bayer, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Sanofi. These companies are constantly researching and developing new drugs to treat prostate cancer, as well as improving existing treatments. Show Less Read more